Kronos Worldwide, Inc. (KRO)

Augmedix Stock Forecast

Stock Price Forecast

The 2 analysts that cover Augmedix stock have a consensus rating of "Strong Sell" and an average price target of $7.75, which forecasts a 49.04% increase in the stock price over the next year. The lowest target is $7.00 and the highest is $8.50.

Price Target: $7.75 (+49.04%)

Analyst Consensus: Strong Sell

Target	Low	Average	Median	High
Price	$7.00	$7.75	$8.50	$8.50
Change	+34.62%	+49.04%	+63.46%	+63.46%

* Price targets were last updated on May 28, 2025.

Analyst Ratings

The average analyst rating for Augmedix stock is "Strong Sell". This means that analysts believe this stock is likely to have very poor returns in the near future.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	1	1	1	1	1	0
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	1	1	1	1	1	1
Strong Sell	1	1	1	1	1	1
Total	3	3	3	3	3	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Leithead Barclays	Barclays	Sell Maintains $10 → $7	Sell	Maintains	$10 → $7	+34.62%	May 28, 2025
Duffy Fischer Goldman Sachs	Goldman Sachs	Strong Sell Maintains $11 → $8.5	Strong Sell	Maintains	$11 → $8.5	+63.46%	May 14, 2025
Michael Leithead Barclays	Barclays	Sell Maintains $9 → $10	Sell	Maintains	$9 → $10	+92.31%	Sep 25, 2024
David Begleiter Deutsche Bank	Deutsche Bank	Strong Buy Maintains $12 → $15	Strong Buy	Maintains	$12 → $15	+188.46%	May 28, 2024
Duffy Fischer Goldman Sachs	Goldman Sachs	Strong Sell Maintains $9 → $11	Strong Sell	Maintains	$9 → $11	+111.54%	May 16, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

2.00B

Increased by 5.77%

from 1.89B

Revenue Next Year

2.22B

Increased by 11.07%

from 2.00B

EPS This Year

0.80

Increased by 6.45%

from 0.75

EPS Next Year

1.14

Increased by 42.41%

from 0.80

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.64B	1.94B	1.93B	1.67B	1.89B	2.00B	2.22B	2.35B
Revenue Growth	-5.33%	18.34%	-0.47%	-13.66%	13.24%	5.77%	11.07%	5.77%
EPS	0.55	0.98	0.90	-0.43	0.75	0.80	1.14	1.38
EPS Growth	-26.51%	76.84%	-7.44%	-	-	6.45%	42.41%	21.33%
Forward PE	-	-	-	-	-	6.52	4.58	3.77
No. Analysts	-	-	-	-	-	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	2.2B	2.4B	2.6B
Avg	2.0B	2.2B	2.3B
Low	1.9B	2.0B	2.1B

Revenue Growth

Revenue Growth	2025	2026	2027
High	14.4%	21.3%	19.2%
Avg	5.8%	11.1%	5.8%
Low	-1.5%	2.4%	-6.0%

EPS Forecast

EPS	2025	2026	2027
High	0.95	1.30	1.48
Avg	0.80	1.14	1.38
Low	0.67	0.99	1.29

EPS Growth

EPS Growth	2025	2026	2027
High	26.1%	63.2%	30.3%
Avg	6.4%	42.4%	21.3%
Low	-11.1%	24.1%	13.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.